Univest
Univest
  • Markets

Godavari Drugs (GODAVARI) Share Price Falls 8.13%: What the Latest Move Shows

  • September 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Godavari Drugs Share Price
Godavari Drugs (GODAVARI) share price fell to Rs 122.55 today, down 8.13% from the previous close. Market cap was Rs 145.59 crore.

Godavari Drugs Share Price fell 8.13% to Rs 122.55, with the company’s market capitalisation at Rs 145.59 crore. According to latest Univest data, the move came after the stock opened at Rs 128, touched a high of Rs 128.05 and a low of Rs 119.45, and was trading below the previous close of Rs 133.4 as of 19 October 2026 at 10:52:58 AM IST. The company is a Micro Cap in Healthcare, and the share price decline has placed Godavari Drugs Share Price and Godavari Drugs Stock News in focus for investors tracking price action, valuation and sector context. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.

Table of Contents

Toggle
  • Godavari Drugs (GODAVARI) Share Price Today: Price Action Analysis
  • Godavari Drugs (GODAVARI) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Godavari Drugs
  • About Godavari Drugs
  • Track Godavari Drugs Share Price on Univest
  • Frequently Asked Questions
    • Why is Godavari Drugs Share Price falling today?
    • What is Godavari Drugs Share Price today?
    • How much did Godavari Drugs share fall today?
    • What is the market capitalisation of Godavari Drugs?
    • What are the key valuation ratios for Godavari Drugs Share Price?
    • What do Godavari Drugs EPS and book value show?
    • How does Godavari Drugs compare with healthcare peers?
    • Is Godavari Drugs Share Price above or below the industry benchmark?
    • Where can investors track Godavari Drugs Share Price and news?

Godavari Drugs (GODAVARI) Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 122.55
Previous Close Rs 133.4
Today's Move -Rs 10.85 (-8.13%)
Open Rs 128
High Rs 128.05
Low Rs 119.45
Market Capitalisation Rs 145.59 crore
Market Cap Category Micro Cap

Godavari Drugs Share Price Today reflects a clear intraday decline, with the stock last traded at Rs 122.55 versus the previous close of Rs 133.4. The day change was Rs -10.85, or -8.13%, after an opening level of Rs 128. The share price moved between Rs 119.45 and Rs 128.05 during the trading session, showing a lower band than the previous close and a softer intraday range for the session. Godavari Drugs Share Price therefore sits at a level below the prior official close, while the market capitalisation of Rs 145.59 crore keeps it in the Micro Cap category. This is the key price action behind today’s Godavari Drugs Share Price fall, and it is the starting point for any Godavari Drugs Stock Analysis. The next question is whether the company’s fundamental profile adds context to this move.

Godavari Drugs Share Price also matters because the day’s range was tight relative to the magnitude of the percentage decline. The stock did not recover to the prior close after opening, and the quoted levels show that the lower end of the range remained in view during the morning session. For readers following Godavari Drugs Share Price Live updates, this is the central market fact: the decline is real, measurable and visible in the day’s opening, high, low and last-traded price.

Godavari Drugs (GODAVARI) Fundamental Analysis

Metric Value
Market Capitalisation Rs 145.59 crore
P/E Ratio 35.03x
P/B Ratio 1.85x
ROE 10.64%
ROCE 10.13%
EPS Rs 3.81
Book Value Per Share Rs 72.07
Dividend Yield 0%

Godavari Drugs (GODAVARI) fundamental metrics show P/E 35.03x, P/B 1.85x, ROE 10.64%, ROCE 10.13%. These figures provide context only and are not a buy or sell signal.

Godavari Drugs has a market capitalisation of Rs 145.59 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 35.03x, P/B at 1.85x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.64% and ROCE of 10.13%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.81, book value per share of Rs 72.07, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 35.03x
Benchmark Median P/E 30.95x
Benchmark Average P/E 46.82x
Benchmark P/E Range 3.1x to 629.67x
Company P/B Ratio 1.85x
Benchmark Median P/B 2.82x
Benchmark Average P/B 4.18x
Company ROE 10.64%
Benchmark Median ROE 10.96%
Benchmark Average ROE 9.51%
Company ROCE 10.13%
Benchmark Median ROCE 13.01%
Benchmark Average ROCE 12.48%
Company Market Capitalisation Rs 145.59 crore
Benchmark Median Market Cap Rs 720.23 crore
Benchmark Average Market Cap Rs 13,282.41 crore

Godavari Drugs (GODAVARI) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Godavari Drugs (GODAVARI) has a P/E ratio of 35.03x, which is above the benchmark median of 30.95x, a difference of +13.18%. On its own, the P/E gap is a valuation reference point, not a trading call.

Godavari Drugs (GODAVARI) has a ROE of 10.64%, which is below the benchmark median of 10.96%, a difference of -2.92%. Godavari Drugs (GODAVARI) has a ROCE of 10.13%, which is below the benchmark median of 13.01%, a difference of -22.14%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries SUNPHARMA 4,22,282.95 34.91 4.88 14.85 19.11
Divi's Laboratories DIVISLAB 2,44,762.03 83.68 13.86 16.19 21.51
Torrent Pharmaceuticals TORNTPHARM 1,73,447.74 79.53 19.32 26.76 19.27
Zydus Lifesciences ZYDUSLIFE 1,12,149.36 24.85 4.16 19.69 21.39
Laurus Labs LAURUSLABS 1,11,250.29 101.75 19.73 18.31 18.2

Godavari Drugs (GODAVARI) has a P/E ratio of 35.03x compared with the displayed peer median of 79.53x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.64% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 10.13% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Godavari Drugs (GODAVARI) has a market capitalisation of Rs 145.59 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Godavari Drugs

  • Godavari Drugs Share Price fell 8.13% and is trading below the previous close of Rs 133.4.
  • The stock is a Micro Cap with market capitalisation of Rs 145.59 crore.
  • P/E of 35.03 is above the industry median of 30.95 but below the industry average of 46.82.
  • P/B of 1.85 is below the industry median of 2.82 and the peer values shown for several listed names.
  • ROE of 10.64% and ROCE of 10.13% offer a compact fundamental snapshot for Godavari Drugs Share Price.

About Godavari Drugs

Godavari Drugs operates in Healthcare and is part of the Pharmaceuticals & Drugs industry. The company’s profile fits a Micro Cap market capitalisation bracket, and its latest numbers place Godavari Drugs Share Price in a valuation framework built around earnings, book value and capital efficiency. The business context is pharmaceutical, so investors typically read Godavari Drugs Stock News alongside industry benchmarks, peer ratios and the company’s reported profitability measures. For Godavari Drugs Share Price, the useful company-level context today is the combination of P/E, P/B, ROE, ROCE, EPS and book value rather than any broad assumption about the sector.

Track Godavari Drugs Share Price on Univest

Use Godavari Drugs (GODAVARI) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Godavari Drugs Share Price on Univest for live levels, valuation ratios, 52-week markers and market insights in one place. The Univest platform also helps you compare Godavari Drugs Share Price Today with peer valuations, sector context and key fundamental ratios. For readers following Godavari Drugs Latest News, this keeps the company’s stock news, price action and fundamentals together in a single view.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Godavari Drugs Share Price falling today?

Ans. Godavari Drugs Share Price fell 8.13% to Rs 122.55 from the previous close of Rs 133.4. According to Univest data, the price event is confirmed, but no company-specific catalyst is established in the verified figures.

What is Godavari Drugs Share Price today?

Ans. Godavari Drugs Share Price was Rs 122.55 as of 19 October 2026 at 10:52:58 AM IST. It traded below the previous close of Rs 133.4 after opening at Rs 128 and touching a low of Rs 119.45.

How much did Godavari Drugs share fall today?

Ans. Godavari Drugs Share Price declined by Rs 10.85, which equals 8.13%. The move took the stock from the prior close of Rs 133.4 to Rs 122.55, with the day’s high at Rs 128.05 and low at Rs 119.45.

What is the market capitalisation of Godavari Drugs?

Ans. Godavari Drugs has a market capitalisation of Rs 145.59 crore. That places the company in the Micro Cap category, which is useful context for understanding Godavari Drugs Share Price and its valuation ratios.

What are the key valuation ratios for Godavari Drugs Share Price?

Ans. The latest figures show a P/E ratio of 35.03 and a P/B ratio of 1.85. For Godavari Drugs Share Price, the P/E sits above the industry median and the P/B sits below the industry median and average.

What do Godavari Drugs EPS and book value show?

Ans. EPS is Rs 3.81 and book value is Rs 72.07 per share. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share for Godavari Drugs Share Price analysis.

How does Godavari Drugs compare with healthcare peers?

Ans. Godavari Drugs Share Price has a P/E of 35.03, close to Sun Pharmaceutical at 34.91 and below several richer peer valuations such as Divi’s Laboratories at 83.68 and Laurus Labs at 101.75.

Is Godavari Drugs Share Price above or below the industry benchmark?

Ans. Godavari Drugs Share Price is above the industry median P/E of 30.95 and below the industry average of 46.82. Its P/B of 1.85 is below both the median of 2.82 and the average of 4.18.

Where can investors track Godavari Drugs Share Price and news?

Ans. Investors can track Godavari Drugs Share Price on Univest for live levels, valuation ratios, 52-week markers and market insights. The same view also keeps Godavari Drugs Stock News and peer context together for quick review.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply